Browse
Submit Data
Databases
API
Help

Dataset Information

33 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

A binuclear vanadium oxyfluoride: di-?-oxido-bis-[(2,2'-bipyrid-yl)fluorido-oxidovanadium(V)].

ABSTRACT: The title compound, [V(2)F(2)O(4)(C(10)H(8)N)(2)], is a centrosymmetric binuclear vanadium(V) species with the metal ions in a distorted octa-hedral environment. The coordination geometries of the symmetry-equivalent V(V) atoms are defined by cis-terminal fluoride and oxide groups, unsymmetrically bridging oxide groups and the N-atom donors of the bipyridyl ligand. The crystal packing is stabilized by weak inter-molecular C-H?O and C-H?F hydrogen bonds.

SUBMITTER: Deburgomaster P

PROVIDER: S-EPMC3007897 | biostudies-literature | 2010

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

A binuclear vanadium oxyfluoride: di-μ-oxido-bis-[(2,2'-bipyrid-yl)fluorido-oxidovanadium(V)].

Deburgomaster Paul P Zubieta Jon J

Acta crystallographica. Section E, Structure reports online 20100811 Pt 9

The title compound, [V(2)F(2)O(4)(C(10)H(8)N)(2)], is a centrosymmetric binuclear vanadium(V) species with the metal ions in a distorted octa-hedral environment. The coordination geometries of the symmetry-equivalent V(V) atoms are defined by cis-terminal fluoride and oxide groups, unsymmetrically bridging oxide groups and the N-atom donors of the bipyridyl ligand. The crystal packing is stabilized by weak inter-molecular C-H⋯O and C-H⋯F hydrogen bonds. ...[more]

PMID: 21588507

Similar Datasets

A binuclear vanadium oxyfluoride: di-μ-oxido-bis-[fluoridooxido(1,10-phenanthro-line)vanadium(V)].

Project description:The title compound, [V(2)F(2)O(4)(C(12)H(8)N(2))(2)], is a centrosymmetric binuclear vanadium(V) species with the metal ions in a distorted octa-hedral environment. The symmetry-equivalent V(V) atoms exhibit coordination geometries defined by cis-terminal fluoride and oxide groups, unsymmetrically bridging oxide groups and the N-atom donors of the phenanthroline ligands. The crystal packing is stabilized by weak inter-molecular C-H⋯O and C-H⋯F hydrogen bonds.

| S-EPMC2983293 | biostudies-literature

A binuclear molybdenum oxyfluoride: ?-oxido-bis-[(2,2'-bipyrid-yl)fluoridodioxidomolybdenum(VI)].

Project description:The title compound, [Mo(2)F(2)O(5)(C(10)H(8)N(2))(2)], is a centrosymmetric binuclear molybdenum(VI) species with the metal atoms in a distorted octa-hedral environment. The coordination geometries of the symmetry-equivalent molybdenum sites are defined by the cis-terminal oxide groups and the N-atom donors of the bipyridyl ligand in the equatorial plane with axial F and bridging O atoms. The bridging O atom occupies a center of symmetry. The mol-ecules stack in the a-axis direction, and the crystal packing is stabilized by weak intra- and inter-molecular C-H?O and C-H?F hydrogen bonds.

| S-EPMC3007386 | biostudies-literature

Poly[4,4'-imino-dipyridinium [tetra-μ(3)-oxido-tetra-oxido-di-μ(4)-phosphato-κO:O':O'':O'''-tetra-vanadium(V)]].

Project description:In the title salt, {(C(10)H(11)N(3))[V(4)O(8)(PO(4))(2)]}(n), cubane-like [V(4)O(8)](4+) clusters are connected by phosphate anions into anionic [V(4)P(2)O(16)](n) (2n-) layers. These aggregate into the three-dimensional structure via N-H⋯O hydrogen-bonding mechanisms imparted by 4,4'-imino-dipyridinium dications situated between the layers.

| S-EPMC2959979 | biostudies-literature

Tetra-ammonium bis-(metforminium) di-μ6-oxido-tetra-μ3-oxido-tetra-deca-μ2-oxido-octa-oxidodeca-vanadium(V) hexa-hydrate.

Project description:The title compound, (NH4)4(C4H12N5)2[V10O28]·6H2O, crystallizes with the deca-vanadate anion placed on an inversion centre in space group P . This anion is surrounded by a first shell of ammonium cations and water mol-ecules, forming efficient N-H⋯O and O-H⋯O hydrogen bonds. A second shell includes metforminium monocations with a twisted geometry, also forming numerous inter-molecular hydrogen bonds. The complex three-dimensional network of non-covalent inter-actions affords a crystal structure in which the cations and anions are densely packed.

| S-EPMC9462348 | biostudies-literature

Crystal structure of μ-oxalodi-hydroxamato-bis-[(2,2'-bipyrid-yl)(di-methyl sulfoxide-κO)copper(II)] bis-(perchlorate).

Project description:The centrosymmetric binuclear complex, [Cu2(C2H2N2O4)(C10H8N2)2(C2H6OS)2](ClO4)2, contains two copper(II) ions, connected through an N-deprotonated oxalodi-hydroxamic acid dianion, two terminal 2,2'-bi-pyridine ligands, and two apically coordinating dimethylsulfoxide mol-ecules. Two non-coordinating perchlorate anions assure electrical neutrality. The copper(II) ions in the complex dication [Cu2(C10H8N2)2(μ-C2H2N2O4)(C2H6SO)2](2+) are in an O2N3 square-pyramidal donor environment, the Cu-Cu separation being 5.2949 (4) Å. Two hydroxamate groups in the deprotonated oxalodi-hydroxamic acid are located trans to one each other. In the crystal, O-H⋯O and C-H⋯O hydrogen bonds link the complex cations to the perchlorate anions. Further C-H⋯O hydrogen bonds combine with π-π contacts with a centroid-to-centroid separation of 3.6371 (12) Å to stack the mol-ecules along the a-axis direction.

| S-EPMC4770973 | biostudies-literature

Di-μ-oxido-bis-({(R)-(-)-2-[1-(2-amino-propyl-imino)eth-yl]-1-naphtholato-κN,N',O}oxidovanadium(V)).

Project description:In the title dinuclear compound, [V(2)(C(15)H(17)N(2)O)(2)O(4)], each V(V) atom is six-coordinated by one oxide group, and by two N and one O atom of the tridentate Schiff base ligand, and bridged by two additional oxide O atoms, resulting in a centrosymmetric dimer. The metal centre has a distorted octa-hedral coordination with the monoanionic Schiff base ligand occupying one equatorial and two axial coordination positions. The separation between V atoms is 3.214 (3) Å. In the crystal structure, there are N-H⋯O, C-H⋯O and C-H⋯π hydrogen bonds, and π-π inter-actions.

| S-EPMC2961648 | biostudies-literature

Bis{[amino-(iminium-yl)meth-yl]urea} tetra-kis-{2-[(di-methyl-amino)(iminium-yl)meth-yl]guanidine} di-μ6-oxido-tetra-μ3-oxido-tetra-deca-μ2-oxido-octa-oxidodeca-vanadium(V) tetra-hydrate.

Project description:The title compound, (C4H12N5)4(C2H7N4O)2[V10O28]·4H2O, is a by-product obtained by reacting ammonium metavanadate(V), metformin hydro-chloride and acetic acid in the presence of sodium hypochlorite, at pH = 5. The crystal structure comprises a deca-vanadate(V) anion (V10O28)6- lying on an inversion centre in space group P , while cations and solvent water mol-ecules are placed in general positions, surrounding the anion, and forming numerous N-H⋯O and O-H⋯O hydrogen bonds. Metforminium (C4H12N5)+ and guanylurea (C2H7N4O)+ cations display the expected shape. Inter-estingly, in physiology the latter cation is known to be the main metabolite of the former one. The reported structure thus supports the role of sodium hypochlorite as an oxidizing reagent being able to degrade metformin hydro-chloride to form guanylurea.

| S-EPMC9462036 | biostudies-literature

Hexa-μ(2)-benzoato-bis-(2,2'-bipyrid-yl)trimanganese(II) monohydrate.

Project description:The complex molecule of the title compound, [Mn(3)(C(7)H(5)O(2))(6)(C(10)H(8)N(2))(2)]·H(2)O, contains a linear array of divalent manganese ions. The central Mn(II) atom, which is located on a crystallographic inversion center, is coordinated octa-hedrally by six benzoate O atoms. The two terminal Mn(II) ions are six-coordinated by four benzoate O atoms and two N atoms of 2,2'-bipyridyl. The central Mn(II) atom and the terminal Mn(II) ions are bridged by four benzoate ligands in a bidentate fashion, whereas the other two carboxyl-ate ligands form bridges through one O atom only and chelate the terminal Mn(II) atom. The mol-ecules pack together via van der Waals attractions and C-H⋯O hydrogen bonds.

| S-EPMC2961620 | biostudies-literature

A monoclinic polymorph of di-μ-oxido-bis-({2-[2-(methyl-amino)ethyl-imino-methyl]phenolato-κN,N',O}oxidovanadium(V)).

Project description:A new monoclinic polymorph of the title compound, [V(2)(C(10)H(13)N(2)O)(2)O(4)], which is a centrosymmetric dimer, crystallizes in space group P2(1)/c, whereas the previously known polymorph crystallizes in the ortho-rhom-bic space group Pbca [Mokry & Carrano (1993 ▶). Inorg. Chem.32, 6119-6121]. Each V(V) atom is six-coordinated by one oxide group, two N atoms and one O atom from the Schiff base ligand, and by two additional bridging O atoms. The two methyl-ene groups are each disordered over two sites, with occupancy factors of 0.776 (14) and 0.224 (14). In the crystal structure, there are C-H⋯O hydrogen bonds and C-H⋯π inter-actions between the dimers.

| S-EPMC2959960 | biostudies-literature

Tris(2,2'-bipyridine)-cobalt(II) μ(6)-oxido-dodeca-μ(2)-oxido-hexa-oxidohexa-molydate(VI).

Project description:In the title compound, [Co(C(10)H(8)N(2))(3)][Mo(6)O(19)], the Co(2+) cation is surrounded in a distorted octa-hedral coordination by six N atoms from three 2,2'-bipyridine ligands. The distribution of Mo-O bond lengths in the Lindqvist isopolyanion is consistent with other structures containing the same unit. In the crystal, the cations and anions are linked by C-H⋯O inter-actions.

| S-EPMC3006945 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data